| Oct'19 | Oct'18 | Oct'17 | Oct'16 | Oct'15 | Oct'14 | Oct'13 | Oct'12 | Oct'11 | Oct'10 | Oct'09 |
|---|---|---|---|---|---|---|---|---|---|---|
Cash flows from operating activities: | ||||||||||
Net loss | ||||||||||
-77,568 | -47,334 | -53,903 | -51,208 | -29,684 | -38,883 | -35,319 | -35,906 | -45,974 | -56,326 | -68,674 |
Adjustments to reconcile net loss to net cash used in operating activities: | ||||||||||
Share-based compensation | ||||||||||
2,804 | 3,238 | 4,585 | 3,425 | 3,157 | 2,908 | 2,226 | 2,054 | 2,577 | 2,965 | 4,815 |
Income from equity investment | ||||||||||
- | - | - | - | - | - | 46 | -645 | 58 | -730 | -812 |
Impairment of equity investment | ||||||||||
- | - | - | - | - | - | - | 3,602 | 0 | 0 | - |
Loss from change in fair value of embedded derivatives | ||||||||||
176 | -60 | -91 | 14 | 23 | 126 | -1,359 | -180 | - | - | - |
Depreciation | ||||||||||
12,353 | 8,648 | 8,518 | 4,949 | 4,099 | - | - | - | - | - | - |
Interest receivable on loan to affiliate | ||||||||||
- | - | - | - | - | - | - | - | - | - | 141 |
Asset Impairment | ||||||||||
- | - | - | - | - | - | - | - | - | 765 | - |
Loss on derivatives | ||||||||||
- | - | - | - | - | - | - | - | - | - | -330 |
Depreciation | ||||||||||
- | - | - | - | - | 4,384 | 4,097 | 5,192 | 6,431 | 7,438 | 8,591 |
Non-cash interest expense on preferred stock and debt obligations | ||||||||||
6,097 | 5,957 | 6,256 | - | - | 2,140 | 2,480 | 2,018 | 2,490 | 91 | 836 |
Deferred income taxes | ||||||||||
0 | -3,035 | 0 | 0 | - | - | - | - | - | - | - |
Impairment of property, plant and equipment and project assets | ||||||||||
20,360 | 0 | 0 | - | - | - | - | - | - | - | - |
Amortization of non-cash interest expense | ||||||||||
- | - | - | 3,207 | 1,830 | - | - | - | - | - | - |
Make whole derivative expense | ||||||||||
- | - | - | - | - | 8,347 | 0 | 0 | - | - | - |
Accretion of redeemable preferred stock of subsidiary | ||||||||||
- | - | - | - | - | - | - | - | -525 | -2,367 | -2,092 |
Unrealized loss on derivative contract | ||||||||||
-624 | 0 | 0 | - | - | - | - | - | -137 | - | - |
Unrealized foreign exchange gains | ||||||||||
29 | 223 | -581 | - | - | - | - | - | - | - | - |
Foreign currency transaction losses (gains) | ||||||||||
- | - | - | 324 | 2,075 | 571 | 443 | - | - | - | - |
Other non-cash transactions, net | ||||||||||
-716 | -760 | -165 | -451 | -412 | -146 | -61 | 297 | 23 | -314 | - |
(Increase) decrease in operating assets: | ||||||||||
Provision (recovery) for doubtful accounts | ||||||||||
- | - | - | - | - | - | - | - | - | - | -32 |
Accounts receivable | ||||||||||
-4,842 | -24,169 | 35,388 | -30,235 | -3,173 | 15,378 | 12,000 | 14,066 | 4,046 | -4,480 | 6,792 |
Unbilled receivables | ||||||||||
4,488 | -24,562 | 15,888 | - | - | - | - | - | - | - | - |
Inventories | ||||||||||
6,427 | -31,714 | 7,972 | 8,052 | 10,100 | -1,059 | 5,901 | 7,600 | 6,697 | 7,971 | 910 |
Project assets | ||||||||||
- | - | - | - | 11,398 | - | 0 | - | - | - | - |
Project assets | ||||||||||
- | - | - | - | 11,398 | 0 | 0 | - | - | - | - |
Other assets | ||||||||||
-2,120 | 2,264 | 714 | 837 | -1,022 | -3,417 | -6,076 | -3,032 | 15,586 | 785 | -2,402 |
Increase (decrease) in operating liabilities: | ||||||||||
Accounts payable | ||||||||||
-173 | -19,846 | 25,020 | -3,019 | -7,224 | -1,566 | 11,776 | -1,790 | 3,405 | 774 | -7,050 |
Accrued liabilities | ||||||||||
2,377 | -11,345 | -2,290 | 1,240 | 6,435 | -11,056 | -172 | -6,081 | 10,761 | 3,762 | 3,786 |
Deferred revenue | ||||||||||
5,996 | 1,261 | -906 | - | - | - | - | - | - | - | - |
Deferred revenue | ||||||||||
- | - | - | -26,648 | -3,898 | -12,289 | 9,148 | -9,642 | 37,573 | 6,404 | -5,268 |
Net cash provided by (used in) operating activities | ||||||||||
- | - | - | - | -44,274 | - | - | - | - | - | - |
Net cash used in operating activities | ||||||||||
-30,572 | 16,322 | -71,845 | -46,595 | - | -57,468 | -16,658 | -58,659 | -8,485 | -34,992 | -65,203 |
Cash flows from investing activities: | ||||||||||
Capital expenditures | ||||||||||
2,151 | 10,028 | 12,351 | 7,726 | 6,930 | 6,295 | 6,551 | 4,453 | 3,350 | 2,481 | 2,588 |
Project asset expenditures | ||||||||||
31,675 | 41,232 | 19,726 | 33,726 | 0 | - | 0 | - | - | - | - |
Project asset acquisition | ||||||||||
35,474 | 0 | -633 | - | - | - | - | - | - | - | - |
Project asset expenditures | ||||||||||
31,675 | 41,232 | 19,726 | 33,726 | 0 | 784 | 0 | - | - | - | - |
Cash acquired from acquisition | ||||||||||
- | - | - | 0 | 0 | - | 357 | 0 | 0 | - | - |
Net cash used in investing activities | ||||||||||
- | - | - | - | -6,930 | - | - | - | - | - | - |
Convertible loan to affiliate | ||||||||||
- | - | - | - | - | - | - | - | 600 | 600 | 600 |
Treasury notes matured | ||||||||||
- | - | - | - | - | - | - | 12,000 | 55,000 | 32,500 | 41,000 |
Treasury notes purchased | ||||||||||
- | - | - | - | - | - | - | - | 33,019 | 59,677 | - |
Net cash used in investing activities | ||||||||||
-69,300 | -51,260 | -31,444 | -41,452 | - | -7,079 | -6,194 | 7,547 | 18,031 | -30,258 | 37,812 |
Cash flows from financing activities: | ||||||||||
Repayment of debt | ||||||||||
48,395 | 16,616 | 8,571 | 30,452 | 1,535 | 5,971 | 374 | 173 | 306 | 377 | 237 |
Proceeds from debt, net of debt discount | ||||||||||
69,596 | 13,091 | 17,877 | 85,935 | 6,763 | - | - | - | - | - | - |
Proceeds from debt | ||||||||||
- | - | - | - | - | 250 | 45,250 | 0 | 4,000 | - | - |
Payment of deferred financing costs | ||||||||||
3,302 | 352 | 206 | 1,758 | 0 | - | - | - | - | - | - |
Proceeds from common stock issuance and warrant exercises, net of registration fees | ||||||||||
- | - | - | 70,929 | 27,060 | - | - | - | - | - | - |
Payment of preferred dividends and return of capital | ||||||||||
1,840 | 4,178 | 4,156 | 4,170 | 4,202 | 4,343 | 4,442 | 7,624 | 15,226 | 3,695 | 3,631 |
Common stock issued for stock plans and related expenses | ||||||||||
23 | 0 | 86 | - | - | - | - | - | - | - | - |
Proceeds from debt | ||||||||||
- | - | - | - | - | - | - | - | - | 0 | 436 |
Proceeds received from noncontrolling interest in subsidiary | ||||||||||
- | - | - | - | - | - | - | 954 | 0 | 0 | - |
Increase in restricted cash and cash equivalents | ||||||||||
- | - | - | - | - | - | 632 | -2,203 | 618 | - | - |
Purchase of non-controlling shares of subsidiary | ||||||||||
- | - | - | 3 | 0 | - | - | - | - | - | - |
Net proceeds from issuance of preferred shares | ||||||||||
- | - | - | - | 0 | - | - | - | - | - | - |
Common stock issued for stock plans and related expenses | ||||||||||
23 | 0 | 86 | 177 | 133 | 161 | 0 | 0 | - | - | - |
Proceeds from sale of common stock and warrant exercises, net | ||||||||||
43,573 | 10,455 | 39,396 | - | - | - | - | - | - | - | - |
Payments of deferred finance costs | ||||||||||
- | - | - | - | - | 0 | 2,472 | 0 | 0 | - | - |
Proceeds from sale of common stock, net | ||||||||||
- | - | - | - | - | 105,844 | 5,040 | 64,003 | 32,930 | 32,104 | 50,332 |
Net cash provided by financing activities | ||||||||||
- | - | - | - | 28,219 | - | - | - | - | - | - |
Common stock issued for stock plans and related expenses | ||||||||||
- | - | - | - | - | - | - | - | - | -151 | 273 |
Net cash provided by financing activities | ||||||||||
59,655 | 27,717 | 72,292 | 120,658 | - | 95,941 | 43,634 | 54,957 | 22,016 | 27,881 | 47,173 |
Effects on cash from changes in foreign currency rates | ||||||||||
-244 | 12 | 129 | -35 | -108 | -260 | 35 | 51 | 4 | 13 | -2 |
Net increase (decrease) in cash, cash equivalents and restricted cash | ||||||||||
-40,461 | -7,209 | -30,868 | 32,576 | -23,093 | 31,134 | - | - | - | - | - |
Net increase (decrease) in cash and cash equivalents | ||||||||||
- | - | - | - | - | - | 20,817 | 3,896 | 31,566 | -37,356 | 19,780 |
Series C Preferred Stock [Member] | ||||||||||
Net proceeds from issuance of preferred shares | ||||||||||
0 | 0 | 27,866 | 0 | - | - | - | - | - | - | - |
Series D Preferred Stock [Member] | ||||||||||
Net proceeds from issuance of preferred shares | ||||||||||
0 | 25,317 | 0 | 0 | - | - | - | - | - | - | - |